Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Market Update

Bell Direct
April 11, 2017

Market Update

Bell Direct
April 10, 2017

Market Update

Julia Lee
April 7, 2017

Market Update

Julia Lee
April 6, 2017

Market Update

Julia Lee
April 5, 2017

Market Update

Julia Lee
April 4, 2017

Market Update

Julia Lee
April 3, 2017

Market Update

Julia Lee
March 31, 2017

Market Update

Julia Lee
March 30, 2017

March Overview

Julia Lee
March 28, 2017

Market Update

Julia Lee
March 27, 2017